Ssp. Gebhart et al., INSULIN-RESISTANCE ASSOCIATED WITH MATERNALLY INHERITED DIABETES AND DEAFNESS, Metabolism, clinical and experimental, 45(4), 1996, pp. 526-531
Maternally inherited diabetes and deafness (MIDD) is a form of diabete
s associated with mutation of mitochondrial DNA (mtDNA) that occurs in
1% to 2% of individuals with diabetes. Understanding the clinical cou
rse and abnormalities in insulin secretion and action in affected indi
viduals should allow better understanding of how this genetic defect a
lters glucose metabolism. We report the clinical course of three indiv
iduals with mtDNA mutations and deafness. Subjects no. 1 and 2 had dia
betes not yet requiring insulin therapy, and subject no. 3, the son of
subject no. 2, had normal glucose tolerance. Defective oxidative phos
phorylation (OXPHOS) based on OXPHOS enzymology of skeletal muscle bio
psy of subjects no. 1 and 2 showed activity of less than 5% of the tol
erance level in complex III for subject no. 1 and in complexes I, I III, and IV for subject no. 2. Assessing insulin secretion using insul
in response to intravenous glucose and insulin sensitivity based on mi
nimal model analysis of an insulin-modified frequently sampled intrave
nous glucose tolerance test (FSIGT), first-phase insulin secretion was
abnormal in subjects no. 1 and 2 and normal in subject no. 3 (AUG, 57
, 93, and 1,235 pmol/mL, respectively). In contrast, all three subject
s had low insulin sensitivity indices (0.04, 0.14, and 0.27 x 10(-4) x
min/pmol/L, respectively). Subject no. 2, who underwent three FSIGT s
tudies over a 16-month interval, showed transient improvement in insul
in release in response to modification of diet and exercise (first-pha
se insulin AUC, 57 pmol/min v 287 pmol/min 10 months later; fasting in
sulin, 97 pmol/Lv237 pmol/L 10 months later), but by 16 months, first-
phase insulin release and fasting insulin had decreased (AUG, 64 and 1
36 pmol/L, respectively) despite higher fasting glucose. We conclude t
hat in our subjects with MIDD, insulin resistance is present and appea
rs to precede defects in insulin release. (C) 1996 by W.B. Saunders Co
mpany